Banyan Biomarkers, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2017-02-07. The offering totals $12.0M, of which $11.4M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| Nancy Denslow, Ph.D. | Director | San Diego, CA |
| Ronald Hayes, Ph.D. | Director | San Diego, CA |
| Jackson Streeter, M.D. | Director | San Diego, CA |
| Frederic Sweeney | Director | San Diego, CA |
| Andrew von Eschenbach, M.D. | Director | San Diego, CA |
| Ronald Hayes, Ph.D. | Executive Officer | San Diego, CA |
| Jackson Streeter, M.D. | Executive Officer | San Diego, CA |
| Ronald Hayes, Ph.D. | Promoter | San Diego, CA |
| Jackson Streeter | Director | Middletown, PA |
| Jackson Streeter | Executive Officer | Middletown, PA |
| William Roper, Jr. | Director | Arlington, VA |
| ANDREW PARKER | Director | Redondo Beach, CA |
| Steven Richieri | Director | SAN DIEGO, CA |
| Steven Richieri | Executive Officer | SAN DIEGO, CA |
| Herbert Boyer | Director | San Diego, CA |
| Stanford Warshawsky | Director | San Diego, CA |
| Nancy Denslow, PhD | Director | San Diego, CA |
| Henry Nordhoff | Director | San Diego, CA |
| Henry Nordhoff | Executive Officer | San Diego, CA |
| Ronald Hayes, PhD | Director | San Diego, CA |
| Ronald Hayes, PhD | Executive Officer | San Diego, CA |
| Andrew von Eschenbach, MD | Director | San Diego, CA |
| Julie Pashkowsky | Executive Officer | San Diego, CA |
| Tony Grover | Executive Officer | San Diego, CA |
| Michael Catania, PhD | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-06-18 | D | $3.0M | $2.3M |
| 2019-01-04 | D | $5.0M | $2.2M |
| 2016-09-27 | D/A | $10.0M | $3.1M |
| 2015-03-18 | D | $5.0M | $1.8M |
| 2014-02-25 | D | $2.0M | $2.0M |
| 2013-07-31 | D | $6.0M | $6.0M |